Skip to main content

Elanco Animal Health Inc

ELAN
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001739104

In the last 90 days, Elanco Animal Health Inc insiders filed 2 open-market purchases and 1 sale; 528 institutions reported holding it in 13F filings for Q2 2026, worth $13.9B in total; Maverick Capital is the only superinvestor holding it.

Key figures

Market capClose on Nov 13, 2026
$13.4B
Insider buysLast 90 days, $1.03M in total
2
Insider sellsLast 90 days, $100.0K in total
1
13F holdersQ2 2026, +11 vs. previous quarter
528
13F valueReported value at the end of Q2 2026
$13.9B
Superinvestors holdingAt the end of Q2 2026
1

Price chart

From SEC filings, in USD.

Revenue, FY2025
$4.71B
+6.2% year over year
Net income, FY2025
-$232.0M
−168.6% year over year
Free cash flow, FY2025
$284.0M
−27.9% year over year
Revenue, Q3 FY2026
$1.26B
+11.3% year over year

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
32.9M
Shares sold short
Change
+1.82M
+5.8% vs. previous
Days to cover
7.18
At average daily volume

Superinvestors holding ELAN, Q2 2026

Go to the superinvestors tab

1 superinvestor reports holding Elanco Animal Health Inc on Form 13F. Percentages are the stock's share of each portfolio.

Maverick Capital

Lee Ainslie

<0.1%

Elanco Animal Health Inc's share of the portfolio

Shares
98,098
Value
$2.41M

Latest insider trades

See all insider trades

Open-market purchases and sales by Elanco Animal Health Inc insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 19, 2026 (view filing)4:15 PM ETOct 154 daysBettington Timothy JSEE REMARKSSSale−4.35K$23.00−$100.0K−3.0%138.9K after10b5-1
Aug 21, 2026 (view filing)4:16 PM ETAug 201 dayKurzius Lawrence ErikDirectorPPurchase+40.0K$23.40+$935.9K+26.9%188.6K after
Aug 18, 2026 (view filing)4:32 PM ETAug 18Same dayO'Neill ShivGC AND CORP SECPPurchase+4.00K$23.58+$94.3K+4.8%87.8K after
Aug 13, 2026 (view filing)4:28 PM ETAug 121 dayHarrington Michael JDirectorPPurchase+5.00K$21.82+$109.1K+4.0%131.5K after
Aug 10, 2026 (view filing)4:14 PM ETAug 73 daysVanHimbergen Robert MEVP and CFOPPurchase+4.20K$23.08+$96.9K+3.2%137.5K after
Aug 10, 2026 (view filing)4:13 PM ETAug 73 daysHerendeen PaulDirectorPPurchase+10.0K$23.69+$236.8K+9.8%111.7K after
May 19, 2026 (view filing)May 154 daysModi Rajeev A.SEE REMARKSPPurchase+4.91K$20.35+$99.9K+3.2%160.8K after
May 19, 2026 (view filing)May 154 daysSimmons Jeffrey NPRESIDENT, CEO AND DIRECTORPPurchase+4.97K$20.09+$99.9K+3.0%172.0K after
Dec 16, 2025 (view filing)Dec 124 daysKurzius Lawrence ErikDirectorPPurchase+10.0K$21.30+$213.0K+8.2%131.8K after
Dec 15, 2025 (view filing)Dec 114 daysModi Rajeev A.SEE REMARKSPPurchase+4.50K$21.33+$96.0K+3.8%123.1K after

Top 10 13F holders, Q2 2026

See all 528 holders

The largest institutional positions in Elanco Animal Health Inc at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding ELAN in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Dodge & Cox67,397,025$1.66B0.87%−1,547,075−2.2%Reduced
FMR LLC56,948,819$1.40B0.06%+6,023,453+11.8%Added
BlackRock, Inc.48,849,973$1.20B0.02%+1,227,343+2.6%Added
Primecap Management Co45,445,012$1.12B0.66%−395,944−0.9%Reduced
T. Rowe Price Investment Management, Inc.28,750,719$707.6M0.46%−5,884,367−17.0%Reduced
Dimensional Fund Advisors LP25,417,271$625.5M0.11%+890,136+3.6%Added
Vanguard Portfolio Management LLC22,672,312$558.0M0.03%+34,955+0.2%Added
Vanguard Capital Management LLC22,607,532$556.4M0.01%+271,408+1.2%Added
State Street Corp16,063,046$395.3M0.01%+726,567+4.7%Added
Winslow Capital Management, LLC13,511,127$332.5M1.14%−103,228−0.8%Reduced

Holders of 5% or more of ELAN

See all 7 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Elanco Animal Health Inc.

Largest holders of ELAN from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
FMR LLC13G/A13.30%66.2M shares+2.80 ppfrom 10.50%Feb 12, 20255 filingsNov 5, 2026SEC
Dodge & Cox13G/A12.30%61.4M shares−1.60 ppfrom 13.90%Jul 8, 20227 filingsNov 12, 2026SEC
Primecap Management Co13G/A9.22%45.8M shares–Feb 12, 20216 filingsMay 13, 2026SEC
BlackRock, Inc.13G8.90%44.0M shares+4.50 ppfrom 4.40%Feb 4, 20253 filingsOct 17, 2025SEC
T. Rowe Price Investment Management, Inc.13G6.40%31.5M sharesNewNov 14, 20251 filingNov 14, 2025SEC

6 members of Congress reported 14 trades in Elanco Animal Health Inc since 2020. Newest filings:

  1. Val T. Hoyle

    House · OR · Oct 10, 2025

    Sell$1K-$15K

  2. Dan Sullivan

    Senate · AK · Jul 26, 2023

    Sell (full)$1K-$15K

  3. Daniel S. Goldman

    House · NY · Apr 17, 2023

    Sell (partial)$1K-$15K

  4. Susie Lee

    House · NV · Dec 29, 2022

    Sell$1K-$15K

  5. Susie Lee

    House · NV · Jul 13, 2021

    Buy$1K-$15K